Pharmacy Fellowship Programs

Fellows will begin with the academic sector at Butler University and then move into their industry setting, Regeneron Pharmaceuticals. The fellow will be spending a majority of their time at the industry partner. The FDA has been an integral part of this fellowship, and we are hopeful to continue with their partnership. Due to the dynamic environment, we have identified additional opportunities for incoming fellows to gain safety and regulatory experience with the industry partners. While we cannot guarantee that fellows will have the opportunity to rotate through the FDA, we are confident that this fellowship will continue to provide high-quality experiences. This program will have one(1) position available for a two-year term (July 2026 through June 2028).

Applications open on September 30, 2025 for the 2026–2028 recruitment cycle and close on October 27, 2025. Please email rxfellowships@butler.edu with any questions you may have.

Butler University College of Pharmacy and Health Sciences

Located in Indianapolis, Indiana, Butler University is a nationally recognized university with seven academic colleges.  In 2025, Butler was ranked as the top regional university in the Midwest by U.S. News & World Report, the most innovative among Midwest Regional Universities.  At the Butler University College of Pharmacy & Health Sciences, you will find a community of health professionals committed to excellence. Our programs prepare students and post-graduate learners to become leaders in their chosen fields. Butler University College of Pharmacy and Health Sciences has a variety of post-graduate residencies and fellowships, each designed to strengthen not only the professionals’ specialty expertise, but also enhance teaching abilities in the classroom through faculty direction and mentorship.

Butler University College of Pharmacy and Health Sciences
4600 Sunset Avenue
Indianapolis, IN 46208

Regeneron Pharmaceuticals

Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved medicines and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.

Regeneron Pharmaceuticals
777 Old Saw Mill River Road
Tarrytown, NY 10591

United States Food and Drug Administration

The Food and Drug Administration is the regulatory, scientific, public health, and consumer protection agency responsible for ensuring that all human and animal drugs, and medical devices are safe and effective, that cosmetics, foods, food additives, drugs and medicated feeds for food producing animal, and radiation emitting devices are safe, and that all such products marketed in the United States are adequately, truthfully and informatively labeled and safely and properly stored, transported, manufactured, packaged, and regulated.

Office of Medication Error Prevention and Risk Management (OMEPRM) includes Division of Medication Error Prevention and Analysis (DMEPA) and Division of Risk Management (DRISK). DMEPA looks to minimize medication errors in the U.S. healthcare system. As part of the FDA preapproval process for new drug products, we review proposed proprietary drug names, container labels and other labeling, packaging, product design, and human factors protocols and study results to prevent medication errors. We also monitor and analyze medication error reports for marketed products to determine if regulatory actions such as labeling revisions or product redesign are needed to address reported errors. DRISK reviews all proposed REMS, REMS modifications, and REMS assessments for all products with approved REMS for conformance with current FDA standards.

Due to the dynamic environment, we cannot guarantee this rotation with the USFDA. However, we are confident the fellow will gain unique regulatory experiences throughout the fellowship.

United States Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993

Fellows will begin with the academic sector at Butler University and then move into their industry setting, Eli Lilly and Company. The fellow will be spending a majority of their time at the industry partner. The FDA has been an integral part of this fellowship, and we are hopeful to continue with their partnership. Due to the dynamic environment, we have identified additional opportunities for incoming fellows to gain safety and regulatory experience with the industry partners. While we cannot guarantee that fellows will have the opportunity to rotate through the FDA, we are confident that this fellowship will continue to provide high-quality experiences.A. This program will have one (1) position available for a two-year term (July 2026 through June 2028).

Butler University College of Pharmacy and Health Sciences

Located in Indianapolis, Indiana, Butler University is a nationally recognized university with seven academic colleges.  In 2025, Butler was ranked as the top regional university in the Midwest by U.S. News & World Report, the most innovative among Midwest Regional Universities.  At the Butler University College of Pharmacy & Health Sciences, you will find a community of health professionals committed to excellence. Our programs prepare students and post-graduate learners to become leaders in their chosen fields. Butler University College of Pharmacy and Health Sciences has a variety of post-graduate residencies and fellowships, each designed to strengthen not only the professionals’ specialty expertise, but also enhance teaching abilities in the classroom through faculty direction and mentorship.

Butler University College of Pharmacy and Health Sciences
4600 Sunset Avenue
Indianapolis, IN 46208

Eli Lilly and Company

For nearly 150 years, Lilly has developed and delivered trusted medicines to more than 58 million people around the world. Their growing portfolio of medicines includes treatments in the areas of cancer, diabetes, endocrinology, immunology, neuroscience, obesity and more. Lilly’s Global Patient Safety organization, consisting of more than 300 physicians, pharmacists, nurses and other health care professionals, is dedicated to the collection, monitoring, evaluation and reporting of safety information through the science of pharmacovigilance.

Eli Lilly and Company
893 Delaware St
Indianapolis, IN 46225

United States Food and Drug Administration

The Food and Drug Administration is the regulatory, scientific, public health, and consumer protection agency responsible for ensuring that all human and animal drugs, and medical devices are safe and effective, that cosmetics, foods, food additives, drugs and medicated feeds for food producing animal, and radiation emitting devices are safe, and that all such products marketed in the United States are adequately, truthfully and informatively labeled and safely and properly stored, transported, manufactured, packaged, and regulated.

Office of Medication Error Prevention and Risk Management (OMEPRM) includes Division of Medication Error Prevention and Analysis (DMEPA) and Division of Risk Management (DRISK). DMEPA looks to minimize medication errors in the U.S. healthcare system. As part of the FDA preapproval process for new drug products, we review proposed proprietary drug names, container labels and other labeling, packaging, product design, and human factors protocols and study results to prevent medication errors. We also monitor and analyze medication error reports for marketed products to determine if regulatory actions such as labeling revisions or product redesign are needed to address reported errors. DRISK reviews all proposed REMS, REMS modifications, and REMS assessments for all products with approved REMS for conformance with current FDA standards.

Due to the dynamic environment, we cannot guarantee this rotation with the USFDA. However, we are confident the fellow will gain unique regulatory experiences throughout the fellowship.

United States Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993